Navigation Links
Eliminating Eye Infection With Antibiotics

A deadly eye infection can now be virtually eliminated by a one-time treatment with an antibiotic say researchers according // to a recent study . Researchers studied a community in Tanzania where the bacterial infection trachoma was running rampant. At the beginning of the study, nearly 10 percent of the population was infected with the bacteria, which causes repeated symptoms that can eventually lead to scarring of the cornea and blindness.

However researchers wanted to evaluate how well a standard practice aimed at eliminating the infection in a community works. The practice calls for everyone in a community where the infection is endemic to be treated with an oral dose of azithromycin. Researchers treated nearly 98 percent of the people living in the community with the medication or, if they could not tolerate the drug, with a tetracycline eye ointment. Researchers measured results over the next two years by testing residents for evidence of the bacteria.

Results showed the treatment was overwhelmingly effective. By the two year follow-up, prevalence of trachoma in the community decreased to less than 1 percent. Thus researchers say their results are extremely encouraging but they say that further research is needed to find an accurate and inexpensive test to determine the prevalence of trachoma in any given community so antibiotics can be directed to the places most in need.
'"/>




Page: 1

Related medicine news :

1. Eliminating Eye Infection With Antibiotics
2. India Targets Eliminating Leprosy
3. Palatal Implant Procedure Proven Effective in Eliminating Snoring
4. Period Eliminating Pills
5. Patients With Filariasis More Prone To HIV Infection
6. Infection linked with heart attack
7. Link Between Infection And Heart Disease
8. Supplements for Ear Infections
9. Once-Daily Cipro(R) XR for Treating Complicated Urinary Tract Infections
10. Oral Medication Effective In Combating Eye Infection
11. The Effectiveness Of Antibacterial Products In Reducing Infection
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2017)... ... ... Republicans in the United States Senate on Thursday released their version of ... differs significantly from the American Health Care Act, which the House passed in May, ... will have to take up the Senate version as-is, if it passes. , The ...
(Date:6/25/2017)... ... 25, 2017 , ... CareSet Labs released the Root NPI Graph today at ... new, greatly improved version of the Doctor Referral teaming dataset commonly available from Medicare. ... subsequently called the the “Doctor Referral Dataset” as released by Medicare and “DocGraph” as ...
(Date:6/25/2017)... , ... June 25, 2017 , ... June is Men’s Health Month and ... most common cancer among men in the U.S. and the third most common cause of ... estimated that one man in seven will be diagnosed with prostate cancer during his lifetime. ...
(Date:6/24/2017)... Erie, PA (PRWEB) , ... June 24, 2017 ... ... was held in Erie, PA at the Sheraton Erie Bayfront and Erie Convention ... hands-on evidence based medicine experience, exhibits, a student quiz bowl, award and scholarship ...
(Date:6/24/2017)... ... ... The weather is heating up and the days are getting longer, providing the ... the summer months provide more than warmer temperatures that are perfect for BBQ’s and ... from direct exposure to the sun. When it comes to the security of homes ...
Breaking Medicine News(10 mins):
(Date:6/16/2017)... , June 16, 2017  Exactly 50 years ago ... off what later became known as the San Francisco "Summer ... ) is unveiling two radical innovations in strategic market research ... This announcement marks the beginning of Northern Light,s "Summer of ... ...
(Date:6/14/2017)... 2017  In 2016, Embodied Labs took ... competition and came away with $25,000 in seed-fund investment. ... Forbes as "entering the life of another" and by ... "empathy to medical professionals in an entirely new dimension." ... a finalist for the Department of Education,s EdSimChallenge, where ...
(Date:6/11/2017)... 10, 2017  Eli Lilly and Company (NYSE: ... 3 studies of galcanezumab, an investigational treatment for the ... on several key secondary endpoints for galcanezumab compared to ... studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented today ... in Boston . ...
Breaking Medicine Technology: